Federal Waiver Secures Future of Hospital-At-Home Care Through 2030

The regulatory uncertainty that threatened the expansion of hospital-at-home care has been resolved. The Centers for Medicare and Medicaid Services approved a waiver extension through September 2030 with bipartisan support. This move provides the legal framework necessary for hospitals to bill Medicare for delivering hospital-level care in patients' residences. Previously, the program relied on temporary waivers that required repeated renewal, creating instability for providers and patients alike.

The program, which originated as a temporary solution during the pandemic, now serves more than 30,000 patients. It is currently active at over 350 hospitals nationwide. The model requires patients to live within 30 minutes of a participating medical center and maintain stability for remote monitoring. Once enrolled, patients receive a tablet for virtual doctor visits and remote monitoring equipment. Nurses make at least two daily in-person visits, while physicians check in virtually. If a patient’s condition deteriorates, protocols allow for rapid transfer back to the medical center.

Colleen Callahan, 75, participated in the program at OSF Healthcare in Peoria, Illinois, in 2024 after being diagnosed with bacterial pneumonia. She initially declined the offer to leave the hospital but accepted after learning more about the logistics. The program provided her with all necessary equipment and training. She noted that the care felt more personal than a traditional hospital stay. Her husband and daughter reported feeling supported by the presence of medical staff in their home.

Akin Demehin of the American Hospital Association described the model as one of the most promising innovations in recent years. He stated that patients are generally billed at the same rate as an in-hospital stay. Insurance coverage typically remains unchanged, as Callahan confirmed with her own claims. Demehin pointed out that freeing up physical beds allows hospitals to admit their sickest patients, a critical benefit during periods of high demand.

Tom Kiesau of the healthcare consulting firm Chartis Group highlighted the financial implications for the government. A 2024 study by the Centers for Medicare and Medicaid Services found that readmission rates and hospital-acquired infections are lower for patients treated at home. Kiesau argued that reduced hospitalization costs lower spending on the taxpayer-funded program. He noted that while the savings will not be immediate, they have substantive economic impacts on the average American.

Krista Drobac of Moving Health Home expressed relief at the regulatory certainty. She stated that the program aligns with patient preferences for care in familiar environments. However, she acknowledged that advocates for family caregivers continue to monitor the strain placed on loved ones. A 2022 study in JAMA Health Forum suggested the model needs better consideration of caregiver effects. Drobac countered that research often shows caregivers experience less stress because they have a professional contact for guidance.

The program remains voluntary and does not replace hospitals for surgeries or complex treatments. Demehin emphasized that hospitals will always be necessary for procedures that cannot be performed at home. According to Moving Health Home, 85% of patients who received care through the program said they would recommend it to family and friends. The next step for the industry is for Congress to consider making the program a permanent fixture of the healthcare system.

The extension of the waiver allows more hospitals to begin onboarding patients with confidence in the payment structure. The model offers an alternative for patients who are stable enough for home monitoring but require hospital-grade attention. As the population ages, providers view this capacity as a necessary component of the healthcare infrastructure.